Most men who undergo radiation therapy (RT) for prostate cancer will develop anejaculation, a new study shows.

ProUroCare Medical, Inc., of Minneapolis, Minn., has filed a de novo application with the FDA seeking marketing clearance for its prostate mechanical imaging (PMI) device (ProUroScan).

Dietary calcium may raise the risk of prostate cancer among Chinese men, recent study findings suggest.

Performing an MRI before a robotic-assisted laparoscopic prostatectomy (RALP) can help urologic surgeons make more informed decisions as to whether to spare the neurovascular bundle and thus preserve erectile function and continence.

CHARLOTTETOWN, Canada—Bone mineral density (BMD) testing and bisphosphonate use are significantly underused in men receiving androgen deprivation therapy (ADT) for prostate cancer (PCa), a new study suggests.

Coffee consumption is not associated with an increased risk of prostate cancer, Korean researchers concluded in a report published online in BJU International.

CHARLOTTETOWN, Canada—New findings from a Canadian study support the use of salvage cryotherapy for prostate cancer (PCa) patients who experience disease recurrence after radiation treatment.

A patient's initial work-up resulted in a diagnosis of prostatitis.

CHICAGO—DNA blood tests under development may provide a more accurate way to detect prostate and breast cancer, according to findings presented at the American Society of Clinical Oncology annual meeting.

Prostate cancer (PCa) patients with PSA levels above 20 ng/mL are not necessarily at high risk for negative outcomes such as prostate cancer-specific mortality (PCSM), but a higher number of risk factors at diagnosis correlates significantly with unfavorable pathology, a study showed.